Fellowship · Hackensack, NJ
Sponsored by Hackensack Meridian Health
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.
The New England journal of medicine · 2022 · 352 citations · Stacey Rifkin-Zenenberg
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Lancet (London, England) · 2023 · 108 citations · Alfred Gillio
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C.
Blood · 2021 · 155 citations · Katherine Armstrong, Stacey Rifkin-Zenenberg
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.
The New England journal of medicine · 2026 · 16 citations · Stacey Rifkin-Zenenberg
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 58 citations · Derek Hanson
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
Neoplasia (New York, N.Y.) · 2023 · 68 citations · Derek Hanson
Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.
Pediatric blood & cancer · 2021 · 90 citations · Burton Appel
OpenPBTA: The Open Pediatric Brain Tumor Atlas.
Cell genomics · 2023 · 67 citations · Derek Hanson